KR100468978B1 - 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 - Google Patents

분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 Download PDF

Info

Publication number
KR100468978B1
KR100468978B1 KR10-2001-7007461A KR20017007461A KR100468978B1 KR 100468978 B1 KR100468978 B1 KR 100468978B1 KR 20017007461 A KR20017007461 A KR 20017007461A KR 100468978 B1 KR100468978 B1 KR 100468978B1
Authority
KR
South Korea
Prior art keywords
polypeptide
sequence
amino acid
pro
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR10-2001-7007461A
Other languages
English (en)
Korean (ko)
Other versions
KR20010101224A (ko
Inventor
데이비드 보츠타인
루크 데스노이어스
나폴레옹 페라라
셔만 퐁
웨이-퀴앙 가오
오드리 고다드
오스틴 엘. 거니
제임스 판
마가렛 안 로이
티모시 에이. 스튜워트
다니엘 투마스
콜린 케이. 와따나베
윌리엄 아이. 우드
Original Assignee
제넨테크, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/012252 external-priority patent/WO1999063088A2/en
Application filed by 제넨테크, 인크. filed Critical 제넨테크, 인크.
Publication of KR20010101224A publication Critical patent/KR20010101224A/ko
Application granted granted Critical
Publication of KR100468978B1 publication Critical patent/KR100468978B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR10-2001-7007461A 1998-12-16 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 Expired - Fee Related KR100468978B1 (ko)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US11314598P 1998-12-16 1998-12-16
US11285198P 1998-12-16 1998-12-16
US60/112,851 1998-12-16
US60/113,145 1998-12-16
US11351198P 1998-12-22 1998-12-22
US60/113,511 1998-12-22
US11556599P 1999-01-12 1999-01-12
US11573399P 1999-01-12 1999-01-12
US11555899P 1999-01-12 1999-01-12
US60/115,565 1999-01-12
US60/115,733 1999-01-12
US60/115,558 1999-01-12
US11934199P 1999-02-09 1999-02-09
US60/119,341 1999-02-09
US11953799P 1999-02-10 1999-02-10
US60/119,537 1999-02-10
US11996599P 1999-02-12 1999-02-12
US60/119,965 1999-02-12
PCT/US1999/012252 WO1999063088A2 (en) 1998-06-02 1999-06-02 Membrane-bound proteins and nucleic acids encoding the same
USPCT/US99/12252 1999-06-02
PCT/US1999/028634 WO2000036102A2 (en) 1998-12-16 1999-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Related Child Applications (4)

Application Number Title Priority Date Filing Date
KR10-2004-7006172A Division KR100468975B1 (ko) 1999-02-12 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
KR10-2004-7006173A Division KR100459831B1 (ko) 1999-01-12 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
KR10-2004-7013508A Division KR100468977B1 (ko) 1998-12-16 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
KR10-2004-7006174A Division KR100468976B1 (ko) 1999-02-10 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산

Publications (2)

Publication Number Publication Date
KR20010101224A KR20010101224A (ko) 2001-11-14
KR100468978B1 true KR100468978B1 (ko) 2005-02-02

Family

ID=27578476

Family Applications (2)

Application Number Title Priority Date Filing Date
KR10-2001-7007461A Expired - Fee Related KR100468978B1 (ko) 1998-12-16 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
KR10-2004-7013508A Expired - Fee Related KR100468977B1 (ko) 1998-12-16 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR10-2004-7013508A Expired - Fee Related KR100468977B1 (ko) 1998-12-16 1999-12-01 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산

Country Status (8)

Country Link
EP (1) EP1141285A2 (enExample)
JP (5) JP2003521229A (enExample)
KR (2) KR100468978B1 (enExample)
AU (7) AU777006B2 (enExample)
CA (1) CA2348757A1 (enExample)
IL (11) IL142794A0 (enExample)
MX (1) MXPA01006057A (enExample)
WO (1) WO2000036102A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7192589B2 (en) 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US6914130B2 (en) * 1998-06-17 2005-07-05 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2008201101B2 (en) * 1999-03-11 2011-01-20 Merck Serono Sa Vascular adhesion molecules and modulation of their function
CN1637019A (zh) 1999-03-11 2005-07-13 Rmf迪克塔吉恩有限公司 血管粘着分子及其功能的调节
KR100543857B1 (ko) * 1999-09-01 2006-01-23 제넨테크, 인크. 혈관신생 및 심혈관형성의 촉진 또는 억제
DE19947010A1 (de) * 1999-09-30 2001-04-05 Universitaetsklinikum Freiburg Das Gen PRV-1 und dessen Verwendung
AU2001259191A1 (en) * 2000-04-28 2001-11-12 Millennium Pharmaceuticals, Inc. 25692, a novel human o-methyltransferase family member and uses thereof
GB0110273D0 (en) * 2001-04-26 2001-06-20 Inpharmatica Ltd Novel proteins
WO2003053334A2 (en) * 2001-12-19 2003-07-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2003097862A1 (en) * 2002-05-17 2003-11-27 Kyowa Hakko Kogyo Co., Ltd. Method of searching substane having antidiabetic activity
WO2004031392A1 (en) * 2002-10-02 2004-04-15 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis
ES2551202T5 (es) 2005-11-04 2018-11-30 Genentech, Inc. Uso de inhibidores de la vía del complemento para tratar enfermedades oculares
AU2007301599B2 (en) 2006-09-28 2013-01-10 Merck Serono S.A. Junctional Adhesion Molecule-C (JAM-C) binding compounds and methods of their use
CN106084054A (zh) 2006-11-02 2016-11-09 健泰科生物技术公司 人源化的抗‑d因子抗体
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
LT2280996T (lt) 2008-05-06 2016-12-12 Genentech, Inc. Subrendusio giminingumo crig variantai
CR20160132A (es) 2013-08-12 2016-08-25 Genentech Inc Composiciones y método para tratar condiciones asociadas con el complemento
SG11201608868PA (en) 2014-05-01 2016-11-29 Genentech Inc Anti-factor d antibody variants and uses thereof
EP3368090A1 (en) 2015-10-30 2018-09-05 H. Hoffnabb-La Roche Ag Anti-factor d antibody variant conjugates and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001970A (en) * 1994-11-07 1999-12-14 Merck & Co., Inc Modified human neuropeptide Y1 Receptors
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
AU746956B2 (en) * 1997-05-06 2002-05-09 Zymogenetics Inc. Novel tumor antigens
DE19818620A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Normal
EP1090118A2 (en) * 1998-06-26 2001-04-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
WO2000004135A2 (en) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Human scad-related molecules, scrm-1 and scrm-2
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
JP2002530080A (ja) * 1998-11-19 2002-09-17 インサイト・ファーマスーティカルズ・インコーポレイテッド 免疫グロブリン・スーパーファミリー・タンパク質
DK1607402T3 (da) * 1999-03-08 2007-04-16 Genentech Inc Sammensætninger og fremgangsmåder til tumorbehandling

Also Published As

Publication number Publication date
AU2004237922A1 (en) 2005-01-13
WO2000036102A3 (en) 2000-11-09
AU2004237921A1 (en) 2005-01-13
AU2004237842B2 (en) 2007-09-20
AU2004237923B2 (en) 2007-09-06
KR20010101224A (ko) 2001-11-14
IL201030A0 (en) 2010-05-17
IL142794A0 (en) 2002-03-10
IL142794A (en) 2008-03-20
MXPA01006057A (es) 2003-09-10
AU2004237923A1 (en) 2005-01-13
AU2004237842A1 (en) 2005-01-13
IL188580A0 (en) 2008-04-13
WO2000036102A2 (en) 2000-06-22
JP2007312779A (ja) 2007-12-06
AU2004237920B2 (en) 2007-08-23
AU2004237919B2 (en) 2007-09-06
AU2004237920A1 (en) 2005-01-13
JP2003521229A (ja) 2003-07-15
IL201001A0 (en) 2010-05-17
KR20040096629A (ko) 2004-11-16
JP2007075118A (ja) 2007-03-29
IL188576A0 (en) 2008-04-13
AU2004237919A1 (en) 2005-01-13
AU2004237922B2 (en) 2007-09-06
AU1932000A (en) 2000-07-03
IL188577A0 (en) 2008-04-13
EP1141285A2 (en) 2001-10-10
AU2004237921B2 (en) 2007-08-23
AU777006B2 (en) 2004-09-30
IL188581A0 (en) 2008-04-13
IL188579A0 (en) 2008-04-13
CA2348757A1 (en) 2000-06-22
JP2004041217A (ja) 2004-02-12
IL200883A0 (en) 2010-05-17
IL188578A0 (en) 2008-04-13
JP2004041218A (ja) 2004-02-12
KR100468977B1 (ko) 2005-02-02

Similar Documents

Publication Publication Date Title
KR100468978B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
US7582293B2 (en) Anti-PRO6308 antibodies
US7297770B2 (en) PRO6496 polypeptides
US7297333B2 (en) Anti-PRO10268 antibodies
US7312303B2 (en) Anti-PRO4980 antibodies
US7504480B2 (en) PRO10275 polypeptides
US20060073555A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6930172B2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060073558A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7332578B2 (en) Anti-pro4407 antibodies
US7235642B1 (en) Anti-PRO 1313 antibodies
US7452975B2 (en) Anti-PRO7168 antibodies
KR100459831B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
KR100468976B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
US20060073556A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
KR100468975B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
US20060073554A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060073557A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060074228A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

A107 Divisional application of patent
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

A107 Divisional application of patent
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20090109

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20100121

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100121